In total, 14 of the 16 patients had significant pain relief when given an intraarticular knee injection with BPC-157 or BPC-157 plus TB4
As of 2026, it was removed from the FDA's Category 2 restriction list and is under active review by the Pharmacy Compounding Advisory Committee, with a scheduled meeting on July 23, 2026, to evaluate its inclusion on the 503A Bulk Drug Substances List
Description BPC-157 BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide studied in preclinical models for its roles in tissue repair signaling, angiogenesis, nitric oxide modulation, and gastrointestinal mucosal research
Circadian Rhythm Disruption as a Root Cause of DepressionCircadian clock gene variants in CLOCK, BMAL1, PER, CRY, NPAS2, and OPN4 interact with light exposure to disrupt hormones, sleep, and mood, increasing risk for depression, anxiety, and seasonal affective disorder